...
xene-img

Xenon Pharmaceuticals Inc, Common Stock

XENE

NMQ

$41.31

+$1.26

(3.15%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.05B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
420.92K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.25
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$35.53 L
$50.99 H
$41.31

About Xenon Pharmaceuticals Inc, Common Stock

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the development of therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN1101, a novel and potent Kv7 potassium channel opener, which is in Phase 3 clinical trials for the treatment of epilepsy and other neurological disorders. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a selective Nav1.6 sodium channel inhibitor that is in Phase 2 clinical trials for the treatment of SCN8A developmental and epileptic encephalopathy, and other indications, including adult focal epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameXENESectorS&P500
1-Week Return-1.76%-3.72%-0.05%
1-Month Return7.83%-1.85%2.75%
3-Month Return3.33%-11.4%7.4%
6-Month Return12.87%-4.41%10.47%
1-Year Return0.39%4.13%27.57%
3-Year Return56.54%0.3%29.56%
5-Year Return218.26%36.62%89.3%
10-Year Return168.42%106.81%206.09%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue6.83M32.17M18.44M9.43M-[{"date":"2019-12-31","value":21.23,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.32,"profit":true},{"date":"2022-12-31","value":29.33,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue38.84M50.52M75.46M105.77M167.51M[{"date":"2019-12-31","value":23.19,"profit":true},{"date":"2020-12-31","value":30.16,"profit":true},{"date":"2021-12-31","value":45.05,"profit":true},{"date":"2022-12-31","value":63.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(32.02M)32.17M18.44M9.43M(167.51M)[{"date":"2019-12-31","value":-99.53,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":57.32,"profit":true},{"date":"2022-12-31","value":29.33,"profit":true},{"date":"2023-12-31","value":-520.77,"profit":false}]
Gross Margin(468.82%)100.00%100.00%100.00%(Infinity%)[{"date":"2019-12-31","value":-468.82,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses49.65M63.47M97.43M138.58M46.54M[{"date":"2019-12-31","value":35.83,"profit":true},{"date":"2020-12-31","value":45.8,"profit":true},{"date":"2021-12-31","value":70.31,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":33.59,"profit":true}]
Operating Income(42.82M)(31.30M)(78.99M)(129.14M)(214.05M)[{"date":"2019-12-31","value":-4281900000,"profit":false},{"date":"2020-12-31","value":-3130100000,"profit":false},{"date":"2021-12-31","value":-7899300000,"profit":false},{"date":"2022-12-31","value":-12914300000,"profit":false},{"date":"2023-12-31","value":-21405400000,"profit":false}]
Total Non-Operating Income/Expense2.12M4.01M571.00K12.60M54.76M[{"date":"2019-12-31","value":3.87,"profit":true},{"date":"2020-12-31","value":7.32,"profit":true},{"date":"2021-12-31","value":1.04,"profit":true},{"date":"2022-12-31","value":23.01,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(41.62M)(29.09M)(78.89M)(125.25M)(182.69M)[{"date":"2019-12-31","value":-4161800000,"profit":false},{"date":"2020-12-31","value":-2909400000,"profit":false},{"date":"2021-12-31","value":-7888800000,"profit":false},{"date":"2022-12-31","value":-12525500000,"profit":false},{"date":"2023-12-31","value":-18268500000,"profit":false}]
Income Taxes(23.00K)(257.00K)(6.00K)118.00K292.00K[{"date":"2019-12-31","value":-7.88,"profit":false},{"date":"2020-12-31","value":-88.01,"profit":false},{"date":"2021-12-31","value":-2.05,"profit":false},{"date":"2022-12-31","value":40.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(41.59M)(28.84M)(78.88M)(125.37M)(182.98M)[{"date":"2019-12-31","value":-4159500000,"profit":false},{"date":"2020-12-31","value":-2883700000,"profit":false},{"date":"2021-12-31","value":-7888200000,"profit":false},{"date":"2022-12-31","value":-12537300000,"profit":false},{"date":"2023-12-31","value":-18297700000,"profit":false}]
Income From Continuous Operations(41.59M)(28.84M)(78.88M)(125.37M)(175.04M)[{"date":"2019-12-31","value":-4159500000,"profit":false},{"date":"2020-12-31","value":-2883700000,"profit":false},{"date":"2021-12-31","value":-7888200000,"profit":false},{"date":"2022-12-31","value":-12537300000,"profit":false},{"date":"2023-12-31","value":-17504500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(41.59M)(28.84M)(78.88M)(125.37M)(182.39M)[{"date":"2019-12-31","value":-4159500000,"profit":false},{"date":"2020-12-31","value":-2883700000,"profit":false},{"date":"2021-12-31","value":-7888200000,"profit":false},{"date":"2022-12-31","value":-12537300000,"profit":false},{"date":"2023-12-31","value":-18239300000,"profit":false}]
EPS (Diluted)(1.54)(0.81)(1.77)(2.04)(2.72)[{"date":"2019-12-31","value":-154,"profit":false},{"date":"2020-12-31","value":-81.49,"profit":false},{"date":"2021-12-31","value":-177,"profit":false},{"date":"2022-12-31","value":-204,"profit":false},{"date":"2023-12-31","value":-272,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

XENE
Cash Ratio 22.02
Current Ratio 22.21

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

XENE
ROA (LTM) -18.92%
ROE (LTM) -26.71%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

XENE
Debt Ratio Lower is generally better. Negative is bad. 0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

XENE
Trailing PE NM
Forward PE NM
P/S (TTM) 181.44
P/B 3.83
Price/FCF NM
EV/R 10874.63
EV/Ebitda NM
PEG NM

FAQs

What is Xenon Pharmaceuticals Inc share price today?

Xenon Pharmaceuticals Inc (XENE) share price today is $41.31

Can Indians buy Xenon Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Xenon Pharmaceuticals Inc (XENE) on Vested. To buy Xenon Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in XENE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Xenon Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Xenon Pharmaceuticals Inc (XENE) via the Vested app. You can start investing in Xenon Pharmaceuticals Inc (XENE) with a minimum investment of $1.

How to invest in Xenon Pharmaceuticals Inc shares from India?

You can invest in shares of Xenon Pharmaceuticals Inc (XENE) via Vested in three simple steps:

  • Click on Sign Up or Invest in XENE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Xenon Pharmaceuticals Inc shares
What is Xenon Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Xenon Pharmaceuticals Inc (XENE) is $50.99. The 52-week low price of Xenon Pharmaceuticals Inc (XENE) is $35.53.

What is Xenon Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Xenon Pharmaceuticals Inc (XENE) is

What is Xenon Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Xenon Pharmaceuticals Inc (XENE) is 3.83

What is Xenon Pharmaceuticals Inc dividend yield?

The dividend yield of Xenon Pharmaceuticals Inc (XENE) is 0.00%

What is the Market Cap of Xenon Pharmaceuticals Inc?

The market capitalization of Xenon Pharmaceuticals Inc (XENE) is $3.05B

What is Xenon Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Xenon Pharmaceuticals Inc is XENE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top